重度抑郁症患者血浆神经元来源细胞外囊泡中线粒体蛋白水平异常
该研究纳入20例重度抑郁症(MDD)患者和10例匹配对照,检测血浆神经元来源细胞外囊泡(NDEV)中线粒体蛋白水平,发现MDD患者治疗前多种线粒体蛋白显著低于对照,而SARM1升高;经SSRI治疗8周后,应答者多数蛋白恢复正常,非应答者未恢复。
要点
- MDD患者基线NDEV中NRF2、CYPD、MFN2、LETM1、SNPH、MYO6、复合体I-6、III-10、NMNAT2、humanin和MOTS-c均低于对照。
- MDD患者基线NDEV中SARM1高于对照,而TFAM和PGC-1α与对照无差异。
- SSRI应答者除复合体I-6、NRF2和PGC-1α外多数线粒体蛋白恢复正常,非应答者未恢复。
核心结论
- MDD患者血浆NDEV中多种线粒体蛋白水平异常,部分蛋白在SSRI应答后恢复正常,提示其可能成为生物标志物和药物靶点。
研究设计与样本
- 研究纳入MDD参与者20例和匹配对照10例,在SSRI治疗前及治疗8周后定量血浆富集NDEV中的功能性线粒体蛋白。
主要发现
- MDD基线NDEV中NRF2、CYPD、MFN2、LETM1、SNPH、MYO6、复合体I亚基6、复合体III亚基10、NMNAT2、humanin和MOTS-c均显著低于匹配对照。
- MDD基线NDEV中SARM1高于对照,TFAM和PGC-1α在MDD与对照间无差异。
- SSRI治疗后,应答者(n=10)除复合体I-6、NRF2和PGC-1α外各功能类线粒体蛋白NDEV水平恢复正常,非应答者(n=10)未恢复正常。
关键数值与推荐
- MDD参与者n=20,匹配对照n=10,SSRI治疗8周,应答者n=10,非应答者n=10。
- MDD基线NDEV中NRF2、CYPD、MFN2、LETM1、SNPH、MYO6、复合体I-6、复合体III-10、NMNAT2、humanin和MOTS-c显著低于对照,SARM1高于对照。
- TFAM和PGC-1α基线NDEV水平在MDD与对照间无差异。
临床怎么用
- 若更大规模研究验证,NDEV线粒体蛋白异常可能作为MDD生物标志物并帮助识别新药靶点。
- SSRI应答者多数NDEV线粒体蛋白恢复正常,非应答者未恢复,提示该指标或有助于疗效评估。
局限性
- 样本量较小(MDD 20例、对照10例),结论需更大规模研究验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
To characterize neuronal mitochondrial abnormalities in major depressive disorder (MDD), functional mitochondrial proteins (MPs) extracted from enriched plasma neuron-derived extracellular vesicles (NDEVs) of MDD participants (n = 20) were quantified before and after eight weeks of treatment with a selective serotonin reuptake inhibitor (SSRI). Pretreatment baseline NDEV levels of the transcriptional type 2 nuclear respiratory factor (NRF2) which controls mitochondrial biogenesis and many anti-oxidant gene responses, regulators of diverse neuronal mitochondrial functions cyclophilin D (CYPD) and mitofusin-2 (MFN2), leucine zipper EF-hand containing transmembrane 1 protein (LETM1) component of a calcium channel/calcium channel enhancer, mitochondrial tethering proteins syntaphilin (SNPH) and myosin VI (MY06), inner membrane electron transport complexes I (subunit 6) and III (subunit 10), the penultimate enzyme of nicotinamide adenine dinucleotide (NAD) generation nicotinamide mononucleotide adenylytransferase 2 (NMNAT2), and neuronal mitochondrial metabolic regulatory and protective factors humanin and mitochondrial open-reading frame of the 12S rRNA-c (MOTS-c) all were significantly lower than those of NDEVs from matched controls (n = 10), whereas those of pro-neurodegenerative NADase Sterile Alpha and TIR motif-containing protein 1 (SARM1) were higher. The baseline NDEV levels of transcription factor A mitochondrial (TFAM) and the transcriptional master-regulator of mitochondrial biogenesis PPAR γ coactivator-1α (PGC-1α) showed no differences between MDD participants and controls. Several of these potential biomarker proteins showed substantially different changes in untreated MDD than those we reported in untreated first-episode psychosis. NDEV levels of MPs of all functional classes, except complex I-6, NRF2 and PGC-1α were normalized in MDD participants who responded to SSRI therapy (n = 10) but not in those who failed to respond (n = 10) by psychiatric evaluation. If larger studies validate NDEV MP abnormalities, they may become useful biomarkers and identify new drug targets.
引用
- Goetzl EJ, Wolkowitz OM, Srihari VH, et al. Abnormal levels of mitochondrial proteins in plasma neuronal extracellular vesicles in major depressive disorder. Mol Psychiatry. 2021. PMID: 34471251. doi:10.1038/s41380-021-01268-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。